Clinical Trials on Glioblastoma or Malignant Glioma in Australia
Total 93 results
-
AmgenCompletedGlioblastoma or Malignant GliomaUnited States, Australia, Netherlands, Germany, Spain, France
-
Sabine Mueller, MD, PhDPacific Pediatric Neuro-Oncology ConsortiumRecruitingGlioblastoma | Malignant Glioma | Recurrent Glioblastoma | Recurrent Malignant Glioma | Recurrent Grade III Glioma | Grade III GliomaUnited States, Australia, Israel, Switzerland
-
AmgenCompletedGlioblastoma Multiforme | Advanced Malignant Glioma | Anaplastic AstrocytomasUnited States, Australia
-
Telix International Pty LtdRecruitingGlioblastoma | Glioblastoma Multiforme | Neoplastic DiseaseAustralia, Austria, Netherlands, New Zealand
-
Telix International Pty LtdCompletedGlioblastoma MultiformeAustria, Australia, Netherlands
-
NuvOx LLCThe AlfredCompletedGlioblastoma MultiformeAustralia
-
Gilead SciencesTerminatedGlioblastoma MultiformeAustralia
-
National Cancer Institute (NCI)Active, not recruitingGlioblastoma | Malignant Glioma | Anaplastic AstrocytomaUnited States, Canada, Puerto Rico, Australia, New Zealand
-
Medical University InnsbruckRoche, AustriaUnknownRecurrent Malignant GliomaAustria
-
Novartis PharmaceuticalsCompletedRecurrent Glioblastoma or Other Glioma SubtypesSpain, Belgium, United States, Switzerland, Australia, Netherlands
-
Nativis, Inc.CompletedGlioblastoma MultiformeAustralia
-
PharmAbcineActive, not recruitingRecurrent GlioblastomaAustralia
-
Northern Sydney and Central Coast Area Health ServiceMerck KGaA, Darmstadt, GermanyUnknownNewly Diagnosed Non Methylated Glioblastoma Multiforme Grade 4Australia
-
University of SydneyCooperative Trials Group for Neuro-OncologyActive, not recruitingGlioblastoma MultiformeUnited States, Australia
-
University of SydneyThe Brain Cancer GroupNot yet recruitingGlioblastoma MultiformeAustralia
-
Queensland Institute of Medical ResearchMerck Sharp & Dohme LLC; Royal Brisbane and Women's Hospital; Princess Alexandra... and other collaboratorsRecruitingGlioblastoma Multiforme | Astrocytoma, Grade IVAustralia
-
Nationwide Children's HospitalPfizerNot yet recruitingGlioblastoma | Glioblastoma Multiforme | High Grade Glioma | Anaplastic Astrocytoma | Diffuse Intrinsic Pontine Glioma | WHO Grade III Glioma | WHO Grade IV Glioma | Infant Type Hemispheric Glioma | Diffuse Midline Glioma, H3K27-alteredUnited States, Australia, Canada, Germany, Netherlands
-
National Cancer Institute (NCI)RecruitingGlioblastoma | Malignant Glioma | Anaplastic Astrocytoma | Anaplastic Astrocytoma, Not Otherwise Specified | Diffuse Intrinsic Pontine Glioma | Diffuse Midline Glioma, H3 K27M-Mutant | Glioblastoma, Not Otherwise SpecifiedUnited States, Australia, New Zealand, Canada
-
Nationwide Children's HospitalNovartisNot yet recruitingGlioblastoma | Glioblastoma Multiforme | High Grade Glioma | Anaplastic Astrocytoma | Diffuse Intrinsic Pontine Glioma | Diffuse Midline Glioma, H3 K27M-Mutant | WHO Grade III Glioma | Metastatic Brain Tumor | WHO Grade IV GliomaUnited States, Australia, United Kingdom, Canada, Germany, Netherlands
-
Nationwide Children's HospitalNot yet recruitingGlioblastoma | Glioblastoma Multiforme | High Grade Glioma | Anaplastic Astrocytoma | Diffuse Intrinsic Pontine Glioma | Diffuse Midline Glioma, H3 K27M-Mutant | WHO Grade III Glioma | Metastatic Brain Tumor | WHO Grade IV GliomaUnited States, Australia, United Kingdom, Canada, Germany, Netherlands
-
Olivia Newton-John Cancer Research InstituteHumanigen, Inc.Completed
-
Kepler University HospitalRecruiting
-
PharmAbcineTerminatedRecurrent GlioblastomaAustralia, United States
-
Activartis BiotechCompleted
-
Nativis, Inc.CompletedGlioblastoma MultiformeUnited States, Australia
-
Medical University InnsbruckPfizerUnknownGlioblastoma MultiformeAustria, Germany
-
AbbVieTerminatedGlioblastoma MultiformeUnited States, Australia, Germany, Netherlands, United Kingdom
-
Novartis PharmaceuticalsCompletedRecurrent Glioblastoma MultiformeUnited States, Belgium, Australia, Spain, France, Canada
-
Celldex TherapeuticsCompletedGlioblastoma | Gliosarcoma | Small Cell Glioblastoma | Giant Cell Glioblastoma | Glioblastoma With Oligodendroglial ComponentUnited States, Canada, Australia, Israel, Taiwan, United Kingdom, Belgium, France, Spain, Germany, Austria, Brazil, Colombia, Czechia, Greece, Hungary, India, Italy, Mexico, Netherlands, New Zealand, Peru, Switzerland, Thailand
-
European Organisation for Research and Treatment...RecruitingFirst Progression of GlioblastomaNetherlands, Austria, Germany
-
Xenova BiomedixWithdrawnGlioblastoma MultiformeUnited States, Australia
-
Forma Therapeutics, Inc.CompletedCohort 1a and 1b: Glioma (Advanced Gliomas and Glioblastoma Multiforme) | Cohort 2a and 2b: Hepatobiliary Tumors (Hepatocellular Carcinoma, Bile Duct Carcinoma, Intrahepatic Cholangiocarcinoma, Other Hepatobiliary Carcinomas) | Cohort 3a and 3b: Chondrosarcoma | Cohort 4a and 4b: Intrahepatic... and other conditionsUnited States, Korea, Republic of, Australia, United Kingdom, Spain, France
-
Ludwig Institute for Cancer ResearchCancer Research Institute, New York City; MedImmune LLC; Cure Brain Cancer Foundation...CompletedGlioblastomaUnited States, Australia
-
Novartis PharmaceuticalsCompletedGlioblastomaAustralia, Spain, Canada, United States
-
PfizerTerminatedAdvanced Breast Cancer (Parts 1 and 2) | Advanced Pancreatic Cancer (Part 1) | Advanced Colorectal Cancer (Part 1) | Advanced Cholangiocarcinoma (Part 1) | Advanced Glioblastoma Multiforme (Part 1)United States, Spain, Hong Kong, Belgium, Australia, France
-
Bristol-Myers SquibbActive, not recruitingRecurrent GlioblastomaPoland, United Kingdom, United States, Spain, Australia, Germany, Italy, Denmark, Belgium, France, Netherlands, Switzerland
-
Hoffmann-La RocheActive, not recruitingGlioblastomaUnited States, Spain, Australia, Canada, Netherlands, Denmark
-
European Organisation for Research and Treatment...Cooperative Trials Group for Neuro-Oncology (COGNO)TerminatedTemozolomide | Low-grade Glioma | Phase III | Wait or TreatSpain, Australia, Switzerland, France, Belgium, Italy, Austria, Netherlands, United Kingdom, Denmark
-
European Organisation for Research and Treatment...Celgene; Canadian Cancer Trials GroupCompletedNewly Diagnosed GlioblastomaUnited States, Belgium, Canada, Spain, Netherlands, France, Switzerland, Germany, Norway, Denmark, Austria, United Kingdom
-
AkesoNot yet recruitingMetastasis | Advanced or Metastatic Solid Tumors | MalignancyAustralia
-
Precision Life Sciences GroupMedelis Inc.SuspendedGlioblastoma MultiformeUnited States, Canada, Austria
-
NovoCure GmbHActive, not recruitingGlioblastoma MultiformeUnited States, United Kingdom, Israel, Germany, Japan, Canada, France, Switzerland, Belgium, Czechia, Austria
-
Medical University of ViennaUnknown
-
AstraZenecaCompletedRecurrent GlioblastomaUnited States, Australia, France, United Kingdom, Germany, Netherlands, Canada, Austria, Belgium, Czech Republic
-
NovoCure Ltd.CompletedGlioblastoma MultiformeUnited States, Spain, France, Canada, Korea, Republic of, Austria, Israel, Czech Republic, Germany, Italy, Sweden, Switzerland
-
St. Olavs HospitalOdense University Hospital; Karolinska University Hospital; Turku University... and other collaboratorsRecruiting
-
Rigel PharmaceuticalsNationwide Children's HospitalNot yet recruitingAstrocytoma | High Grade Glioma | Oligodendroglioma | Diffuse Intrinsic Pontine Glioma | Diffuse Midline Glioma, H3 K27M-Mutant | WHO Grade III Glioma | Metastatic Brain Tumor | Spinal Tumor | Astrocytoma, Grade III | Astrocytoma, Grade IV | IDH1 Mutation | WHO Grade IV Glioma | Thalamus Tumor | IDH1 R132 | IDH1 R132C | IDH1 R132H and other conditionsUnited States, Australia, United Kingdom, Canada, Germany, Netherlands
-
European Organisation for Research and Treatment...Tragara Pharmaceuticals, Inc.CompletedGlioblastoma | Astrocytoma, Grade IIIFrance, Austria, Germany, Netherlands, Switzerland
-
NovoCure Ltd.CompletedRecurrent Glioblastoma MultiformeUnited States, Israel, Switzerland, Austria, Czech Republic, France, Germany